The TIL-based therapies market is projected to be worth over USD 4.3 billion, by 2030, claims Roots Analysis
LONDON, ENGLAND, UNITED KINGDOM, October 5, 2021 /EINPresswire.com/ -- Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status
Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings.
To order this 255+ page report, which features 90+ figures and 100+ tables, please visit
A detailed assessment of the current market landscape of TIL-based therapies with respect to type of developer (industry / non-industry), phase of development (preclinical, phase I, phase I/II and phase II), therapeutic area (hematological cancer, solid tumor and others), popular target indications (melanoma, ovarian cancer, pancreatic cancer, head and neck cancer, sarcoma, colon cancer, acute myeloid leukemia, stomach cancer, chronic lymphocytic leukemia, cervical cancer, breast cancer and others), source of T-cells (autologous and allogeneic), dose frequency (single dose, multiple dose and split dose), target patient segment (children, adults and elderly patients) and type of therapy (monotherapy and combination therapy). Further, the chapter provides detail on the most active players (in terms of number of pipeline candidates) engaged in this domain.
An analysis highlighting the key opinion leaders (KOLs) in this domain. It features a 2×2 matrix assessing the relative experience of KOLs shortlisted based on their contributions (in terms of involvement in various clinical studies) in this field, and a schematic world map representation, indicating the geographical location of eminent scientists / researchers engaged in the development of TIL-based therapies.
Detailed profiles of therapies being evaluated in clinical stages (phase I/II or above); each profile features an overview of the therapy, its mechanism of action, current development status, key clinical trial results, dosage regimen and manufacturing information.
An overview of key therapeutic areas that are being targeted by TIL-based therapies. It also includes an assessment of the opportunity (in terms of revenue generation potential from therapy sales) across oncological disease indications.
An analysis of the partnerships that have been established in the recent past, covering R&D agreements, license agreements (specific to technology platforms and product candidates), product development and commercialization agreements, manufacturing agreements, clinical trial collaborations, product supply management agreements, joint ventures and others.
An analysis of investments that have been made into companies which have proprietary TIL-based products / technologies. The various type of funding instances reported in this domain include seed financing, venture capital financing, capital raised from IPOs and subsequent public offerings, grants, and debt financing.
A case study on manufacturing of cell therapy products, highlighting the key challenges associated with the production of such therapies. In addition, it features a detailed list of contract service providers and in-house manufacturers engaged in this market.
An elaborate discussion on various factors that form the basis for the pricing of cell-based therapies. It features different models / approaches that a pharmaceutical company may adopt, in order to decide the price of a TIL-based therapy.
A review of the key promotional strategies that have been adopted by developers of marketed T-cell therapies, namely KYMRIAH® and YESCARTA®.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
Acute Lymphoblastic Leukemia
Key Geographical Regions
To request a sample copy / brochure of this report, please visit
Key Questions Answered
What are the prevalent R&D trends related to TIL-based therapies?
Who are the leading industry and non-industry players engaged in the development of TIL-based therapies?
What challenges are commonly faced by stakeholders engaged in this domain?
Who are the key investors in this domain?
Who are the key opinion leaders / experts engaged in this upcoming field of therapeutics?
Which types of partnership models are commonly adopted by industry stakeholders?
Which regions are key contract manufacturing hubs for TIL-based therapies?
Which factors are likely to influence the evolution of this upcoming market?
How is the current and future market opportunity likely to be distributed across key market segments?
You may also be interested in the following titles:
1. Global T-Cell Therapies Market (5th Edition): Industry Trends and Global Forecasts, 2021-2030
2. CAR-T Cell Therapies Market (3rd Edition): Industry Trends and Global Forecasts, 2021-2030
3. TCR-based Therapies Market: Industry Trends and Global Forecasts, 2021-2030
4. Cell and Gene Therapy CROs Market: Industry Trends and Global Forecasts (2nd Edition), 2021-2030
5. Gene Therapy Market (4th Edition): Industry Trends and Global Forecasts, 2020-2030
+1 (415) 800 3415
+44 (122) 391 1091
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
+1 (415) 800 3415
+44 (122) 391 1091
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at email@example.com
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The TIL-based therapies market is projected to be worth over USD 4.3 billion, by 2030, claims Roots Analysis here
News-ID: 2416697 • Views: 141
More Releases from Roots Analysis
Novel Drug Reconstitution Systems Market, 2021-2030
In 2018, seven out of ten top-selling prescription medicines were biologics. The liquid formulations of biologics are not much stable and tend to lose efficacy with time due to the changes in their pharmacokinetic and pharmacodynamic properties. Therefore, lyophilization of such drugs is essential before their storage. Around 50% of the biologics intended for parenteral administration are available in lyophilized form, which require reconstitution before administration. To Request for sample -
Squamous Non-small Cell Lung Cancer Market, 2021-2031 by Roots Analysis
Advances in molecular biology and tumor immunology have enabled the development of NSCLC targeting therapies, which have the ability to impede cancer growth by altering chemical reactions associated with oncogenic driver mutations Roots Analysis has announced the addition of “Squamous Non-small Cell Lung Cancer Market, 2021-2031” report to its list of offerings. Success of approved squamous non-small cell lung cancer therapies, such as Keytruda®, Opdivo® and Portrazza®, has resulted in a
The TIL-based therapies market is projected to be worth over USD 4.3 billion, by …
Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings. Given the frequently reported inadequacies of conventional cancer therapies and the growing need for personalized medicine, there is a marked surge
The novel ocular drug delivery devices market is projected to grow at a CAGR of …
The delivery of drugs in ocular regions is known to be considerably more challenging; several pharmaceutical companies are actively undertaking initiatives to identify novel approaches for safe and efficient administration of therapies to eyes Roots Analysis has announced the addition of the “Novel Ocular Drug Delivery Devices Market, 2021 – 2030” report to its list of offerings. Over the years, a number of companies have developed several novel and advanced drug
More Releases for Industry
Global Bisphenol A Industry
Global Bisphenol A market size is accounted for $14.6 billion in 2014 and is expected to grow at a CAGR of 5.2% to reach $21.9 billion by 2022. The drivers of the market are raising demand for polycarbonate plastics and epoxy resins, growth in global automobile sector and rapid growth in demand for Bisphenol A in developing countries. The challenges faced by the market are volatility in crude oil prices
Global Nutraceuticals Market By Application | Food Industry, Ink Industry, Medic …
Researchmoz added Most up-to-date research on "Global Nutraceuticals Market By Application | Food Industry, Ink Industry, Medicine Industry, Electronic Industry and Paint Industry" to its huge collection of research reports. This report studies Nutraceuticals in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers
Global Email Marketing Industry
Albany, New York, May 10, 2017: The increasing number of internet users and the rising of the retail/e-commerce industry across the globe is likely to boost the demand for email marketing over the next few years. This rapidly rising global email marketing industry is the focus of a new market report recently added to the massive online repository of Market Research Reports Search Engine (MRRSE) with a title of “Email
Digital Transformation / “Industry 4.0”
Wesseling, April 12th 2017: When humans, machines and industrial processes are intelligently connected then we are speaking about “Industry 4.0”. Thus it is possible to create and provide customised products and services whereat most modern information and communication technologies are used. Intelligent, digital and flexible cross-linked systems and production processes form the technical basis for well- and efficiently-designed processes. UIM is working within the digital transformation section today and acquired
2016 Connector Industry Yearbook
ReportsWorldwide has announced the addition of a new report title 2016 Connector Industry Yearbook to its growing collection of premium market research reports. Each year, Bishop & Associates prepares the Connector Industry Yearbook based on annual reports provided by publicly traded connector companies. Income statements and balance sheets are consolidated for the past 10 years, 5 years, and most current year, providing benchmarks on the industry and the overall performance
Notes: Sales, means the sales volume of Embedded Analytics Revenue, means the sales value of Embedded Analytics Get Sample Copy of Report: https://goo.gl/OUc8J0 This report studies sales (consumption) of Embedded Analytics in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Microsoft Corporation IBM Corporation SAP SE Opentext Corporation Microstrategy, Inc. Logi Analytics, Inc. Sisense, Inc. Birst, Inc. Information Builders Tibco Software, Inc. Qlik